Isofol Medical Q2’21: Funding Completed in Run-Up to Crucial Read-out - Redeye

Redeye views the Q2 update on the ongoing AGENT trial as positive. We have adjusted our valuation range to account for the completed share issues.

Länk till analysen i sin helhet: https://www.redeye.se/research/819368/isofol-medical-q221-funding-completed-in-run-up-to-crucial-read-out?utm_source=finwire&utm_medium=RSS